A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Lorlatinib Impurity 20 | CAS 2541062-07-9 - Request Quote

Picture of Lorlatinib Impurity 20

Lorlatinib Impurity 20

SZ CAT No:SZ-L054026
CAS No
2541062-07-9
Mol.F.
C22H22FN6O6P
Mol.Wt.
516.4
Inv. Status
Synthesis on demand

Shipping Temperature :

HSN Code :

Country of Origin :

Smiles :

Usage Note:

Lorlatinib Impurity 20 is chemically . Lorlatinib Impurity 20 is supplied with detailed characterization data compliant with regulatory guideline. Lorlatinib Impurity 20 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Lorlatinib.

The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.

Applications & Regulatory Use Cases

Buy 2541062-07-9

Purchase 2541062-07-9

Order 2541062-07-9

Enquire 2541062-07-9

price of 2541062-07-9

2541062-07-9 Supplier

2541062-07-9 Manufacturer

2541062-07-9 Exporter

buy high quality Lorlatinib Impurity 20

Purchase Lorlatinib Impurity 20

Lorlatinib Impurity 20 suppliers

Lorlatinib Impurity 20 manufacturers

Lorlatinib Impurity 20 price

Order Lorlatinib Impurity 20

Enquire Lorlatinib Impurity 20

Lorlatinib Impurity 20 cost

Lorlatinib Impurity 20 Supplier

Lorlatinib Impurity 20 Distributor

Lorlatinib Impurity 20 for Method Validation

Lorlatinib Reference Standard

Lorlatinib Impurity 20 for ANDA Filing

Lorlatinib Impurity 20 for Forced Degradation Studies

Lorlatinib Impurity 20 Identification Standards

Lorlatinib Impurity 20 for DMF Filing

ℹ️

Disclaimer

SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.

SynZeal will update these details as per new developments or findings in product specifications without further notice.

,